ArticleBMC microbiology2026
Characterization of pulmonary tuberculosis in high-altitude region using nanopore targeted sequencing.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and spatial distribution of pulmonary tuberculosis in China: a surveillance study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundXizang (formerly known as Tibet in English) has one of the highest tuberculosis (TB) incidence rates in China. The region's extreme altitudes (≥ 3000 m) and hypoxic environment present substantial challenges for conventional diagnostic methods. Additionally, the clinical and biological characteristics of TB at high altitudes remain poorly understood.
methodTB-seq, a third-generation nanopore-targeted sequencing method, was used to analyze sputum samples from 158 confirmed pulmonary TB patients in Xizang. Bacterial load was quantified, a drug-resistance gene landscape was generated, and these findings were correlated with clinical phenotypes. A matched low-altitude group (< 1000 m) was included to investigate the effects of altitude on Mycobacterium tuberculosis biology.
resultIn Xizang, retreatment cases accounted for the majority of TB patients (58.23%). Type I TB was the most common form (79.75%), while non-type I forms were observed only in retreatment patients (P < 0.01). Bacterial load decreased significantly with increasing age (P < 0.001), was higher in retreatment cases (P = 0.013), and positively correlated with white blood cell and neutrophil counts (P < 0.05). Drug-resistant mutations were identified in 22.78% of patients, primarily as mono-resistance (63.9%), with key resistance-associated genes being rpsL (47.2%), rpoB (38.9%), and katG (33.3%). Compared to low-altitude controls, the high-altitude group had a significantly lower bacterial load (P < 0.01), reduced overall drug resistance (23.7% vs. 38.2%, P < 0.01), no rrs mutations, and a significantly lower pncA mutation rate (P < 0.05).
conclusionTuberculosis in Xizang is marked by a high proportion of retreatment cases, low pathogen burden, and a reduced rate of drug resistance-associated gene mutations. Altitude appears to suppress bacterial quantity and may select for specific resistance mechanisms. These findings support the need for targeted TB control strategies in Xizang and underscore the complex interactions among the environment, the pathogen, and the host.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.